Additional file 5. Multidimensional scaling analysis of the 45-gene signature and disease-free survival analysis. (A) Ordination plots of multidimensional scaling analysis of the signature in HCC cohorts using Euclidean distances revealed significant separation of tumor (T) and non-tumor (NT) samples represented in a 2-dimensional space. Axes represent the first and second dimension. The distinction of T and NT was confirmed by PERMANOVA tests. (B) Kaplan-Meier plot of disease-free survival in HCC patients from the GSE14520 cohort stratified into low- and high-risk groups using the 45-gene signature. Disease-free survival is defined as the time from surgery to recurrence, death from any cause or distant metastasis. P-values are calculated f...
Additional file 5. Distribution of expression of signature genes in low- and high-risk patients. (A)...
Additional file 5: Figure S4. Comparison of our signature with six previous models using time-depend...
Additional file 16. Kaplan-Meier plot depicting combined relation of CDKN2A mutation status with the...
Additional file 9. Ordination plots of multidimensional scaling analysis of the 8-gene signature in ...
Additional file 11. Kaplan-Meier plot of disease-free survival in HCC patients from the GSE14520 coh...
Additional file 13. Ordination plots of multidimensional scaling analysis of the 8-gene signature in...
Additional file 14. Univariate and multivariate Cox proportional hazards analysis of risk factors as...
Additional file 3. Genes associated with tumor hypoxia and T-cell infiltration. (A) Box plot depicts...
Additional file 12. Correlation of risk scores, as determined using the 8-gene signature, and hypoxi...
Additional file 15. Correlation of risk scores, as determined using the 8-gene signature, and hypoxi...
Additional file 10. Expression distribution of genes from the 8-gene signature according to tumor st...
Additional file 1. Abbreviations and number of tumor and non-tumor samples in TCGA cancers
Additional file 4. The 45-gene signature associated with tumor hypoxia and T-cell infiltration
Additional file 4. Additional tumor subgroup analyses and evaluation of prognosis predictive perform...
Additional file 4: Figure S3. LASSO profiles of the 368 prognostic genes in HCC. (A) LASSO coefficie...
Additional file 5. Distribution of expression of signature genes in low- and high-risk patients. (A)...
Additional file 5: Figure S4. Comparison of our signature with six previous models using time-depend...
Additional file 16. Kaplan-Meier plot depicting combined relation of CDKN2A mutation status with the...
Additional file 9. Ordination plots of multidimensional scaling analysis of the 8-gene signature in ...
Additional file 11. Kaplan-Meier plot of disease-free survival in HCC patients from the GSE14520 coh...
Additional file 13. Ordination plots of multidimensional scaling analysis of the 8-gene signature in...
Additional file 14. Univariate and multivariate Cox proportional hazards analysis of risk factors as...
Additional file 3. Genes associated with tumor hypoxia and T-cell infiltration. (A) Box plot depicts...
Additional file 12. Correlation of risk scores, as determined using the 8-gene signature, and hypoxi...
Additional file 15. Correlation of risk scores, as determined using the 8-gene signature, and hypoxi...
Additional file 10. Expression distribution of genes from the 8-gene signature according to tumor st...
Additional file 1. Abbreviations and number of tumor and non-tumor samples in TCGA cancers
Additional file 4. The 45-gene signature associated with tumor hypoxia and T-cell infiltration
Additional file 4. Additional tumor subgroup analyses and evaluation of prognosis predictive perform...
Additional file 4: Figure S3. LASSO profiles of the 368 prognostic genes in HCC. (A) LASSO coefficie...
Additional file 5. Distribution of expression of signature genes in low- and high-risk patients. (A)...
Additional file 5: Figure S4. Comparison of our signature with six previous models using time-depend...
Additional file 16. Kaplan-Meier plot depicting combined relation of CDKN2A mutation status with the...